The Retia Medical Mission
To improve healthcare through advanced technology.
Retia’s first product is a patient monitor for tracking cardiac output (blood flow rate). The initial target market for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology.
Our team consists of MIT-trained businesspeople and scientists. We have extensive startup and Fortune 500 experience conceiving, developing and launching new products. In addition, we have a strong clinical and business advisory board consisting of experts in critical care and medical devices.
Life at Retia Medical
Our people are capable and exercise good judgment. If you're coding all day, wear what you like. If you're meeting with customers or investors, then dress accordingly. Above all, you must have a bias for action, willingness to debate, and flexibility to change course.